The Chemours Company (NYSE: CC), a global chemistry company with
leading market positions in Thermal & Specialized Solutions,
Titanium Technologies, and Advanced Performance Materials,
announced the appointment of Damián Gumpel as President of
Chemours’ Titanium Technologies (TT) business segment, effective
March 3, 2025. Diane Iuliano Picho, who has served as Interim TT
Business President since March 2024 has been appointed Chief
Enterprise Enablement Officer, effective March 3, 2025. Both will
report to Chemours President and CEO, Denise Dignam and serve on
the Chemours Executive Team.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20250117002959/en/
Damián Gumpel, President of Chemours’
Titanium Technologies (TT) business segment, effective March 3,
2025. (Photo: Business Wire)
“After a comprehensive global search, Damián Gumpel was the
clear choice to lead our Titanium Technologies business into the
future. Damián’s proven track record of strategic vision, cost
transformation, and commercial excellence within the chemical
industry will strengthen the TT business,” said Denise Dignam,
President and CEO of Chemours. “I am confident that under Damián’s
leadership, our TT business will continue building on the success
of the TT Transformation Plan and contribute significantly to
Chemours’ Pathway to Thrive strategy."
Damián Gumpel joins Chemours with deep chemical industry
leadership experience. At the Olin Corporation, he most recently
served as Vice President, Corporate Strategy, helping to define a
new corporate strategy and executing a joint venture and several
M&A transactions. Previously, he led Olin’s global leading
Epoxy business, where he delivered cost reductions and successfully
executed a portfolio realignment, and Olin’s Chlor Alkali Products
and Vinyls business, where he led a business transformation that
delivered record EBITDA improvement. At Dow Inc., he held several
business leadership roles within Dow’s leading chlor-alkali and
vinyls business.
“I am honored to lead Chemours Titanium Technologies, one of the
most trusted and respected TiO2 businesses in the world,” said
Gumpel. “Together, we will drive stronger operational performance
and productivity while deepening Chemours’ reputation as a safe and
great place to work for employees, trusted partner to our
customers, suppliers and communities, and consistent value driver
for shareholders.”
Chemours also announces that Matthew Abbott, Senior Vice
President and Chief Enterprise Transformation Officer, has elected
to leave the company to pursue a new opportunity, effective
February 3, 2025.
“We thank Matt for his eight years of service, including
stepping up as Interim Chief Financial Officer for Chemours last
year. Matt served with the highest levels of integrity and
partnership at an important inflection point for our company. For
that, and his many lasting contributions to our business, we thank
him and wish him well in his future endeavors,” said Denise
Dignam.
With Abbott’s departure, Ms. Picho will now lead the newly
organized Enterprise Enablement unit designed to accelerate the
Operational Excellence and Growth Enablement pillars of Chemours’
Pathway to Thrive strategy. Her portfolio will include Procurement
and key Centers of Excellence, including Manufacturing, Commercial,
and Digital, with a mandate to improve Chemours’ Order to Cash and
critical operational processes across the company. Ms. Picho brings
over 40 years of business leadership spanning each of Chemours’
three business segments.
“Diane has long been one of the most trusted and admired
executives at Chemours, with a comprehensive understanding of our
company that will be an immense asset to the Chemours Executive
Team. Her leadership of the Enterprise Enablement unit will be a
key driver to realizing our full potential as Chemours,” said
Dignam.
About The Chemours Company The Chemours Company (NYSE:
CC) is a global leader in providing industrial and specialty
chemicals products for markets, including coatings, plastics,
refrigeration and air conditioning, transportation, semiconductor
and advanced electronics, general industrial, and oil and gas.
Through our three businesses – Thermal & Specialized Solutions,
Titanium Technologies, and Advanced Performance Materials – we
deliver application expertise and chemistry-based innovations that
solve customers’ biggest challenges. Our flagship products are sold
under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™,
Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware
and listed on the NYSE under the symbol CC, Chemours has
approximately 6,100 employees and 28 manufacturing sites and serves
approximately 2,700 customers in approximately 110 countries.
For more information, visit chemours.com or follow us on X
(formerly Twitter) @Chemours or LinkedIn.
Forward-Looking Statements This press release contains
forward-looking statements, within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, which involve risks and uncertainties.
Forward-looking statements provide current expectations of future
events based on certain assumptions and include any statement that
does not directly relate to a historical or current fact. The words
"believe," "expect," "will," "anticipate," "plan," "estimate,"
"target," "project" and similar expressions, among others,
generally identify "forward-looking statements," which speak only
as of the date such statements were made. These forward-looking
statements may address, among other things, the impact of
individual expertise on overall company performance, all of which
are subject to substantial risks and uncertainties that could cause
actual results to differ materially from those expressed or implied
by such statements. Forward-looking statements are based on certain
assumptions and expectations of future events that may not be
accurate or realized, such as full year guidance relying on models
based upon management assumptions regarding future events that are
inherently uncertain. These statements are not guarantees of future
performance. Forward-looking statements also involve risks and
uncertainties that are beyond Chemours' control. Matters outside
our control, including general economic conditions, geopolitical
conditions and global health events, have affected or may affect
our business and operations and may or may continue to hinder our
ability to provide goods and services to customers, cause
disruptions in our supply chains such as through strikes, labor
disruptions or other events, adversely affect our business
partners, significantly reduce the demand for our products,
adversely affect the health and welfare of our personnel or cause
other unpredictable events. Additionally, there may be other risks
and uncertainties that Chemours is unable to identify at this time
or that Chemours does not currently expect to have a material
impact on its business. Factors that could cause or contribute to
these differences include the risks, uncertainties and other
factors discussed in our filings with the U.S. Securities and
Exchange Commission, including in our Annual Report on Form 10-K
for the year ended December 31, 2023 and our Quarterly Report on
Form 10-Q for the quarter ended September 30, 2024. Chemours
assumes no obligation to revise or update any forward-looking
statement for any reason, except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250117002959/en/
INVESTORS Brandon Ontjes VP, Head of Strategy &
Investor Relations +1.302.773.3300 investor@chemours.com
NEWS MEDIA Cassie Olszewski Media Relations &
Reputation Leader +1.302.219.7140 media@chemours.com
Chemours (NYSE:CC)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Chemours (NYSE:CC)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025